Results 51 to 60 of about 748,093 (313)
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Brief Report: Renal replacement therapy in Korea, 2010
Kidney Research and Clinical Practice, 2012 The Korean Society of Nephrology (KSN) launched the official End-Stage Renal Disease (ESRD) Patient Registry in 1985 and the Internet online registry program was opened in 2001. The ESRD Registry Committee of KSN has collected data on dialysis therapy in
Dong Chan Jin +6 more
doaj +1 more source
Value of Registries for EVAR [PDF]
European Journal of Vascular and Endovascular Surgery, 2005 There is no doubt we live in the era of evidence-based medicine. The call for evidence in any part of medical practice is nowadays stronger than ever. In contrast, however, to what happened with carotid endarterectomy, the rapid increase in the performance of which followed the publication of the randomised trials, the endovascular revolution in the ...
Liapis, CD, Kakisis, JD
openaire +3 more sources
Registrations in the AEA RCT Registry (2013-05-15 through 2022-07-01)
This dataset contains publicly available data on the American Economic Association's RCT registry downloaded 2022-07 ...
AEA RCT Registry
core +1 more source
NASA-PDS/pds-registry-app: pds-registry-app v1.1.0-SNAPSHOT
, 2021 Registry application enabling a PDS node to register all its data products for long term preservation and sharing with the rest of the PDS ...
TESTPERSONAL +11 more
core +1 more source
Molecular Oncology, EarlyView.The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
BMC Cancer, 2020 Following publication of the original article [1], an error was reported in the author group. The correct author group should read as follows:
Anita Feller +12 more
doaj +1 more source
BMC Women's Health, 2022 Highlights The burden of cancer among people aged 20–49 is unequally distributed between men and women in Geneva. Women had 1.6- and five-times higher rates than men respectively for invasive and non-invasive cancers.
Elisabetta Rapiti +2 more
doaj +1 more source
Registrations in the AEA RCT Registry (2013-05-15 through 2021-10-10)
This dataset contains publicly available data on the American Economic Association's RCT registry downloaded 2021-10 ...
AEA RCT Registry
core +1 more source
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola +11 more
wiley +1 more source